CompletedNot Applicable

Cardiovascular Registry of Atrial Fibrillation

Argentina2,016 participantsStarted 2020-08-04

Plain-language summary

Follow a representative sample of Latin American patients diagnosed with atrial fibrillation to set data on demographic characteristics, documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 18 years-old that signed informed consent; * Atrial Fibrillation or Atrial Flutter at the time of inclusion documented in source document; * If the patient is not in atrial fibrillation or Atrial Flutter rhythm, s/he should have 2 electrographic records, at least 15 days apart between them, with one of them being performed within the last 6 months before enrollment (AF may be documented by 12-lead ECG, Holter monitor-24h); Exclusion Criteria: * Patients who did not agree to participate. * Patients without possibility of monitoring for one year.

What they're measuring

INR control rate

Timeframe: 12 months

Oral anticoagulation discontinuation rate

Timeframe: 12 months

Percentage of death

Timeframe: 12 months

Percentage of stroke

Timeframe: 12 months

Percentage of systemic embolism

Timeframe: 12 months

Percentage of myocardial infarction

Timeframe: 12 months

Percentage of major bleeding

Timeframe: 12 months

Percentage of electrical cardioversion

Timeframe: 12 months

Percentage of percutaneous ablation of AF

Timeframe: 12 months

Trial details

NCT IDNCT04456842

SponsorBrazilian Clinical Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-13

View on ClinicalTrials.gov More Atrial Fibrillation trials